[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Oral Vaccine Market Research Report 2024(Status and Outlook)

September 2024 | 132 pages | ID: G8E7224AF301EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The Global Human Oral Vaccine Market Size was estimated at USD 1571.03 million in 2023 and is projected to reach USD 2266.65 million by 2029, exhibiting a CAGR of 6.30% during the forecast period.

This report provides a deep insight into the global Human Oral Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Oral Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Oral Vaccine market in any manner.

Global Human Oral Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Other

Market Segmentation (by Application)

Child

Aldult

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Human Oral Vaccine Market
  • Overview of the regional outlook of the Human Oral Vaccine Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Oral Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Human Oral Vaccine
1.2 Key Market Segments
  1.2.1 Human Oral Vaccine Segment by Type
  1.2.2 Human Oral Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HUMAN ORAL VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Human Oral Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Human Oral Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HUMAN ORAL VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Global Human Oral Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Oral Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Oral Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Oral Vaccine Sales Sites, Area Served, Product Type
3.6 Human Oral Vaccine Market Competitive Situation and Trends
  3.6.1 Human Oral Vaccine Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Human Oral Vaccine Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 HUMAN ORAL VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Human Oral Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HUMAN ORAL VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 HUMAN ORAL VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Oral Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Oral Vaccine Price by Type (2019-2024)

7 HUMAN ORAL VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Oral Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Oral Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Oral Vaccine Sales Growth Rate by Application (2019-2024)

8 HUMAN ORAL VACCINE MARKET SEGMENTATION BY REGION

8.1 Global Human Oral Vaccine Sales by Region
  8.1.1 Global Human Oral Vaccine Sales by Region
  8.1.2 Global Human Oral Vaccine Sales Market Share by Region
8.2 North America
  8.2.1 North America Human Oral Vaccine Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Human Oral Vaccine Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Human Oral Vaccine Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Human Oral Vaccine Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Human Oral Vaccine Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Merck
  9.1.1 Merck Human Oral Vaccine Basic Information
  9.1.2 Merck Human Oral Vaccine Product Overview
  9.1.3 Merck Human Oral Vaccine Product Market Performance
  9.1.4 Merck Business Overview
  9.1.5 Merck Human Oral Vaccine SWOT Analysis
  9.1.6 Merck Recent Developments
9.2 GSK
  9.2.1 GSK Human Oral Vaccine Basic Information
  9.2.2 GSK Human Oral Vaccine Product Overview
  9.2.3 GSK Human Oral Vaccine Product Market Performance
  9.2.4 GSK Business Overview
  9.2.5 GSK Human Oral Vaccine SWOT Analysis
  9.2.6 GSK Recent Developments
9.3 Sanofi
  9.3.1 Sanofi Human Oral Vaccine Basic Information
  9.3.2 Sanofi Human Oral Vaccine Product Overview
  9.3.3 Sanofi Human Oral Vaccine Product Market Performance
  9.3.4 Sanofi Human Oral Vaccine SWOT Analysis
  9.3.5 Sanofi Business Overview
  9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
  9.4.1 Lanzhou Institute Human Oral Vaccine Basic Information
  9.4.2 Lanzhou Institute Human Oral Vaccine Product Overview
  9.4.3 Lanzhou Institute Human Oral Vaccine Product Market Performance
  9.4.4 Lanzhou Institute Business Overview
  9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
  9.5.1 Serum Institute Human Oral Vaccine Basic Information
  9.5.2 Serum Institute Human Oral Vaccine Product Overview
  9.5.3 Serum Institute Human Oral Vaccine Product Market Performance
  9.5.4 Serum Institute Business Overview
  9.5.5 Serum Institute Recent Developments
9.6 Valneva
  9.6.1 Valneva Human Oral Vaccine Basic Information
  9.6.2 Valneva Human Oral Vaccine Product Overview
  9.6.3 Valneva Human Oral Vaccine Product Market Performance
  9.6.4 Valneva Business Overview
  9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
  9.7.1 Shanghai United Cell Human Oral Vaccine Basic Information
  9.7.2 Shanghai United Cell Human Oral Vaccine Product Overview
  9.7.3 Shanghai United Cell Human Oral Vaccine Product Market Performance
  9.7.4 Shanghai United Cell Business Overview
  9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
  9.8.1 Bibcol Human Oral Vaccine Basic Information
  9.8.2 Bibcol Human Oral Vaccine Product Overview
  9.8.3 Bibcol Human Oral Vaccine Product Market Performance
  9.8.4 Bibcol Business Overview
  9.8.5 Bibcol Recent Developments
9.9 PaxVax
  9.9.1 PaxVax Human Oral Vaccine Basic Information
  9.9.2 PaxVax Human Oral Vaccine Product Overview
  9.9.3 PaxVax Human Oral Vaccine Product Market Performance
  9.9.4 PaxVax Business Overview
  9.9.5 PaxVax Recent Developments
9.10 Vabiotech
  9.10.1 Vabiotech Human Oral Vaccine Basic Information
  9.10.2 Vabiotech Human Oral Vaccine Product Overview
  9.10.3 Vabiotech Human Oral Vaccine Product Market Performance
  9.10.4 Vabiotech Business Overview
  9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
  9.11.1 Tiantan Biological Human Oral Vaccine Basic Information
  9.11.2 Tiantan Biological Human Oral Vaccine Product Overview
  9.11.3 Tiantan Biological Human Oral Vaccine Product Market Performance
  9.11.4 Tiantan Biological Business Overview
  9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
  9.12.1 EuBiologics Human Oral Vaccine Basic Information
  9.12.2 EuBiologics Human Oral Vaccine Product Overview
  9.12.3 EuBiologics Human Oral Vaccine Product Market Performance
  9.12.4 EuBiologics Business Overview
  9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
  9.13.1 Panacea Biotec Ltd Human Oral Vaccine Basic Information
  9.13.2 Panacea Biotec Ltd Human Oral Vaccine Product Overview
  9.13.3 Panacea Biotec Ltd Human Oral Vaccine Product Market Performance
  9.13.4 Panacea Biotec Ltd Business Overview
  9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
  9.14.1 Bio-Med Human Oral Vaccine Basic Information
  9.14.2 Bio-Med Human Oral Vaccine Product Overview
  9.14.3 Bio-Med Human Oral Vaccine Product Market Performance
  9.14.4 Bio-Med Business Overview
  9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
  9.15.1 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Basic Information
  9.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Overview
  9.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Market Performance
  9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
  9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments

10 HUMAN ORAL VACCINE MARKET FORECAST BY REGION

10.1 Global Human Oral Vaccine Market Size Forecast
10.2 Global Human Oral Vaccine Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Human Oral Vaccine Market Size Forecast by Country
  10.2.3 Asia Pacific Human Oral Vaccine Market Size Forecast by Region
  10.2.4 South America Human Oral Vaccine Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Human Oral Vaccine by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Human Oral Vaccine Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Human Oral Vaccine by Type (2025-2030)
  11.1.2 Global Human Oral Vaccine Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Human Oral Vaccine by Type (2025-2030)
11.2 Global Human Oral Vaccine Market Forecast by Application (2025-2030)
  11.2.1 Global Human Oral Vaccine Sales (Kilotons) Forecast by Application
  11.2.2 Global Human Oral Vaccine Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Oral Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Oral Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Oral Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Oral Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Oral Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2022)
Table 10. Global Market Human Oral Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Oral Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Oral Vaccine Product Type
Table 13. Global Human Oral Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Oral Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Oral Vaccine Market Challenges
Table 22. Global Human Oral Vaccine Sales by Type (Kilotons)
Table 23. Global Human Oral Vaccine Market Size by Type (M USD)
Table 24. Global Human Oral Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Oral Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Oral Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Oral Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Oral Vaccine Sales (Kilotons) by Application
Table 30. Global Human Oral Vaccine Market Size by Application
Table 31. Global Human Oral Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Oral Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Oral Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Oral Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Oral Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Oral Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Oral Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Oral Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Oral Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Oral Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Oral Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Human Oral Vaccine Basic Information
Table 44. Merck Human Oral Vaccine Product Overview
Table 45. Merck Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Human Oral Vaccine SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Human Oral Vaccine Basic Information
Table 50. GSK Human Oral Vaccine Product Overview
Table 51. GSK Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Human Oral Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Human Oral Vaccine Basic Information
Table 56. Sanofi Human Oral Vaccine Product Overview
Table 57. Sanofi Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Human Oral Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Human Oral Vaccine Basic Information
Table 62. Lanzhou Institute Human Oral Vaccine Product Overview
Table 63. Lanzhou Institute Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Human Oral Vaccine Basic Information
Table 67. Serum Institute Human Oral Vaccine Product Overview
Table 68. Serum Institute Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Human Oral Vaccine Basic Information
Table 72. Valneva Human Oral Vaccine Product Overview
Table 73. Valneva Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Human Oral Vaccine Basic Information
Table 77. Shanghai United Cell Human Oral Vaccine Product Overview
Table 78. Shanghai United Cell Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Human Oral Vaccine Basic Information
Table 82. Bibcol Human Oral Vaccine Product Overview
Table 83. Bibcol Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Human Oral Vaccine Basic Information
Table 87. PaxVax Human Oral Vaccine Product Overview
Table 88. PaxVax Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Human Oral Vaccine Basic Information
Table 92. Vabiotech Human Oral Vaccine Product Overview
Table 93. Vabiotech Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Human Oral Vaccine Basic Information
Table 97. Tiantan Biological Human Oral Vaccine Product Overview
Table 98. Tiantan Biological Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Human Oral Vaccine Basic Information
Table 102. EuBiologics Human Oral Vaccine Product Overview
Table 103. EuBiologics Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Human Oral Vaccine Basic Information
Table 107. Panacea Biotec Ltd Human Oral Vaccine Product Overview
Table 108. Panacea Biotec Ltd Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Human Oral Vaccine Basic Information
Table 112. Bio-Med Human Oral Vaccine Product Overview
Table 113. Bio-Med Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. Global Human Oral Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Human Oral Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Human Oral Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Human Oral Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Human Oral Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Human Oral Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Human Oral Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Human Oral Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Human Oral Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Human Oral Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Human Oral Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Human Oral Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Human Oral Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Human Oral Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Human Oral Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Human Oral Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Human Oral Vaccine Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Human Oral Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Oral Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Human Oral Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Human Oral Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Oral Vaccine Market Size by Country (M USD)
Figure 11. Human Oral Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Oral Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Oral Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Oral Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Oral Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Oral Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Oral Vaccine by Type in 2023
Figure 20. Market Size Share of Human Oral Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Oral Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Oral Vaccine Market Share by Application
Figure 24. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Oral Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Oral Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Oral Vaccine Market Share by Application in 2023
Figure 28. Global Human Oral Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Oral Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Oral Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Oral Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Oral Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Oral Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Oral Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Oral Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Oral Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Human Oral Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Oral Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Oral Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Oral Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Oral Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Oral Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Oral Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Oral Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Oral Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Human Oral Vaccine Market Share Forecast by Application (2025-2030)


More Publications